Lency Gu, Head of Business Development at Haisco Pharmaceutical Group, says the Chinese bio pharmaceutical firm is looking for more partnerships to help its global expansion. The company has announced a new license agreement with US-based AirNexis Therapeutics. Gu explains significance of the deal on "Bloomberg: The China Show." (Source: Bloomberg)